Published January 2015 | Version v1
Journal article

Optimized protocol for the radioiodination of hydrazone-type polymer drug delivery systems

Description

Hydrazone conjugates of polymers with doxorubicin represent a very promising tool for cancer chemotherapy. However, these conjugates are very difficult to radiolabel with iodine radionuclides, which possess otherwise very advantageous nuclear properties to, e.g., follow biodistribution. In this study, we developed a robust protocol for the high-yield radioiodination of hydrazone-type drug delivery systems with doxorubicin. In particular, it is crucial that the polymer radioiodination step be performed before the deprotection of the hydrazide and doxorubicin binding. - Highlights: • Hydrazone-type drug delivery systems with doxorubicin were radioiodinated. • Radioiodination was performed via polymer-bound phenolic moiety. • Radioiodination step must be performed before deprotection and drug binding

Availability note (English)

Available from http://dx.doi.org/10.1016/j.apradiso.2014.10.016

Additional details

Identifiers

DOI
10.1016/j.apradiso.2014.10.016;
PII
S0969-8043(14)00371-6;

Publishing Information

Journal Title
Applied Radiation and Isotopes
Journal Volume
95
Journal Issue
Complete
Journal Page Range
p. 129-134
ISSN
0969-8043
CODEN
ARISEF

INIS

Country of Publication
United Kingdom
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
46103147
Subject category
S07: ISOTOPES AND RADIATION SOURCES;
Descriptors DEI
CHEMOTHERAPY; DELIVERY; DOXORUBICIN; HYDRAZONES; IODINE ISOTOPES; LABELLING; NEOPLASMS; PHENOLS; POLYMERS; RADIOISOTOPES; YIELDS
Descriptors DEC
ANTIBIOTICS; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC DRUGS; AROMATICS; DISEASES; DRUGS; HYDROXY COMPOUNDS; ISOTOPES; MEDICINE; ORGANIC COMPOUNDS; ORGANIC NITROGEN COMPOUNDS; THERAPY

Optional Information

Copyright
Copyright (c) 2014 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.